US Stock MarketDetailed Quotes

OMGA Omega Therapeutics

Watchlist
  • 1.320
  • +0.060+4.76%
Close Sep 27 16:00 ET
  • 1.360
  • +0.040+3.02%
Post 20:02 ET
72.80MMarket Cap-929P/E (TTM)

Omega Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
181.16%2.13M
357.36%2.36M
49.25%3.09M
34.56%989K
39.66%831K
59.45%759K
92.54%516K
1,339.58%2.07M
410.42%735K
595K
Operating revenue
181.16%2.13M
357.36%2.36M
49.25%3.09M
34.56%989K
39.66%831K
59.45%759K
92.54%516K
1,339.58%2.07M
410.42%735K
--595K
Cost of revenue
Gross profit
Operating expense
-40.78%18.71M
-13.38%22.81M
-1.42%103.36M
-31.59%21.69M
-10.71%23.73M
20.01%31.6M
30.19%26.33M
58.42%104.84M
52.35%31.7M
54.35%26.58M
Selling and administrative expenses
-11.94%5.77M
18.47%7.4M
10.62%26.19M
-14.57%6.16M
51.39%7.87M
5.72%6.56M
15.48%6.24M
42.58%23.67M
26.60%7.21M
16.57%5.2M
-General and administrative expense
-11.94%5.77M
18.47%7.4M
10.62%26.19M
-14.57%6.16M
51.39%7.87M
5.72%6.56M
15.48%6.24M
42.58%23.67M
26.60%7.21M
16.57%5.2M
Research and development costs
-48.33%12.94M
-23.27%15.42M
-4.93%77.17M
-41.44%15.72M
-20.30%16.48M
29.17%25.04M
41.58%20.09M
69.57%81.17M
83.28%26.84M
68.20%20.67M
Other operating expenses
----
----
----
----
-185.67%-610K
----
----
----
----
50.53%712K
Operating profit
46.24%-16.58M
20.79%-20.45M
2.44%-100.26M
33.16%-20.7M
11.86%-22.9M
-19.29%-30.84M
-29.36%-25.82M
-55.63%-102.77M
-49.86%-30.97M
-50.89%-25.99M
Net non-operating interest income expense
-68.76%299K
-51.47%331K
1,165.77%2.81M
96.37%487K
271.74%684K
1,840.00%957K
540.00%682K
124.40%222K
246.75%248K
154.28%184K
Non-operating interest income
-68.76%299K
-51.47%331K
1,165.77%2.81M
----
----
--957K
--682K
--222K
----
----
Total other finance cost
----
----
----
----
-271.74%-684K
----
----
----
----
-154.28%-184K
Other net income (expense)
-112.24%-24K
93.71%-9K
114.65%23K
98.13%-2K
-1,550.00%-29K
6,633.33%196K
-186.00%-143K
88.27%-157K
-409.52%-107K
100.21%2K
Other non- operating income (expenses)
-112.24%-24K
93.71%-9K
114.65%23K
98.13%-2K
-1,550.00%-29K
6,633.33%196K
-186.00%-143K
-460.71%-157K
-409.52%-107K
0.00%2K
Income before tax
45.08%-16.31M
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
-39.24%-25.8M
Income tax
Net income
45.08%-16.31M
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
-39.24%-25.8M
Net income continuous Operations
45.08%-16.31M
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
-39.24%-25.8M
Minority interest income
Net income attributable to the parent company
45.08%-16.31M
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
-39.24%-25.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
45.08%-16.31M
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
-39.24%-25.8M
Basic earnings per share
44.44%-0.3
28.00%-0.36
15.89%-1.8
43.75%-0.36
25.93%-0.4
0.00%-0.54
-19.05%-0.5
29.84%-2.14
-45.45%-0.64
5.26%-0.54
Diluted earnings per share
44.44%-0.3
28.00%-0.36
15.89%-1.8
43.75%-0.36
25.93%-0.4
0.00%-0.54
-19.05%-0.5
29.84%-2.14
-45.45%-0.64
5.26%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 181.16%2.13M357.36%2.36M49.25%3.09M34.56%989K39.66%831K59.45%759K92.54%516K1,339.58%2.07M410.42%735K595K
Operating revenue 181.16%2.13M357.36%2.36M49.25%3.09M34.56%989K39.66%831K59.45%759K92.54%516K1,339.58%2.07M410.42%735K--595K
Cost of revenue
Gross profit
Operating expense -40.78%18.71M-13.38%22.81M-1.42%103.36M-31.59%21.69M-10.71%23.73M20.01%31.6M30.19%26.33M58.42%104.84M52.35%31.7M54.35%26.58M
Selling and administrative expenses -11.94%5.77M18.47%7.4M10.62%26.19M-14.57%6.16M51.39%7.87M5.72%6.56M15.48%6.24M42.58%23.67M26.60%7.21M16.57%5.2M
-General and administrative expense -11.94%5.77M18.47%7.4M10.62%26.19M-14.57%6.16M51.39%7.87M5.72%6.56M15.48%6.24M42.58%23.67M26.60%7.21M16.57%5.2M
Research and development costs -48.33%12.94M-23.27%15.42M-4.93%77.17M-41.44%15.72M-20.30%16.48M29.17%25.04M41.58%20.09M69.57%81.17M83.28%26.84M68.20%20.67M
Other operating expenses -----------------185.67%-610K----------------50.53%712K
Operating profit 46.24%-16.58M20.79%-20.45M2.44%-100.26M33.16%-20.7M11.86%-22.9M-19.29%-30.84M-29.36%-25.82M-55.63%-102.77M-49.86%-30.97M-50.89%-25.99M
Net non-operating interest income expense -68.76%299K-51.47%331K1,165.77%2.81M96.37%487K271.74%684K1,840.00%957K540.00%682K124.40%222K246.75%248K154.28%184K
Non-operating interest income -68.76%299K-51.47%331K1,165.77%2.81M----------957K--682K--222K--------
Total other finance cost -----------------271.74%-684K-----------------154.28%-184K
Other net income (expense) -112.24%-24K93.71%-9K114.65%23K98.13%-2K-1,550.00%-29K6,633.33%196K-186.00%-143K88.27%-157K-409.52%-107K100.21%2K
Other non- operating income (expenses) -112.24%-24K93.71%-9K114.65%23K98.13%-2K-1,550.00%-29K6,633.33%196K-186.00%-143K-460.71%-157K-409.52%-107K0.00%2K
Income before tax 45.08%-16.31M20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M-39.24%-25.8M
Income tax
Net income 45.08%-16.31M20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M-39.24%-25.8M
Net income continuous Operations 45.08%-16.31M20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M-39.24%-25.8M
Minority interest income
Net income attributable to the parent company 45.08%-16.31M20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M-39.24%-25.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 45.08%-16.31M20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M-39.24%-25.8M
Basic earnings per share 44.44%-0.328.00%-0.3615.89%-1.843.75%-0.3625.93%-0.40.00%-0.54-19.05%-0.529.84%-2.14-45.45%-0.645.26%-0.54
Diluted earnings per share 44.44%-0.328.00%-0.3615.89%-1.843.75%-0.3625.93%-0.40.00%-0.54-19.05%-0.529.84%-2.14-45.45%-0.645.26%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data